Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Carboxylic acids and derivatives
(total 141 related compounds in database, current show from 131 to 140)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-tetradecanoylamino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES + N H H H HN O H + N H H H + N H H H O H 3 C N HN O H + N H H H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-[(9E,12E)-octadeca-9,12-dienoyl]amino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES O + N H H H + N H H H N H H + N H H H + N H H H CH 3 O N N H O H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
[(2S)-6-azaniumyl-1-[3-[3-[[(2S)-2,6-bis(azaniumyl)hexanoyl]amino]propyl-[(E)-octadec-9-enoyl]amino]propylamino]-1-oxohexan-2-yl]azanium Depiction based on curated SMILES O + N H H H + N H H H N H H + N H H H + N H H H CH 3 O N N H O H Staphylococcus Biofilm Preclinical (in vitro) Konai MM, et al. 2015. ACS Infect Dis
Leucettamine D Depiction based on curated SMILES OH H 2 N N HO O N Vibrio Biofilm Preclinical (in vitro) Mai T, et al. 2015. Lett Appl Microbiol
Di-isonaamidine A Depiction based on curated SMILES N HO N HO OH HO O N N NH N O N H N O HN O N H Vibrio Biofilm Preclinical (in vitro) Mai T, et al. 2015. Lett Appl Microbiol
(4E)-2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzylidene)-1,3-oxazol-5(4H)-one Depiction based on curated SMILES CH 3 O CH 3 O O O Cl H 3 C Cl N O Yersinia TTSS secreted effectors Preclinical (in vitro) Hu X, et al. 2013. Bioorg Med Chem Lett
2-hydroxy-5-[5-[(E)-3-oxo-3-[[3-oxo-3-[(3-phenyl-1,2,4-thiadiazol-5-yl)amino]propyl]amino]prop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O OH O HO N S N N H O N H Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
2-hydroxy-5-[5-[(E)-3-[[3-[[3-(4-hydroxyphenyl)-1,2,4-thiadiazol-5-yl]amino]-3-oxopropyl]amino]-3-oxoprop-1-enyl]furan-2-yl]benzoic acid Depiction based on curated SMILES O O OH O OH HO N S N N H O N H Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
5-cyano-6-[(4-methylphenyl)methylsulfanyl]pyridine-2-carboxylic acid Depiction based on curated SMILES N N HO O CH 3 S Escherichia
Yersinia		 TTSS (Type III secretion system)
TTSS (Type III secretion system)		 Preclinical (in vitro)
Preclinical (in vitro)		 Pan NJ, et al. 2009. Antimicrob Agents Chemother
5-[5-[(E)-3-[[(1S)-1-carboxy-2-(4-nitrophenyl)ethyl]amino]-3-oxoprop-1-enyl]furan-2-yl]-2-hydroxybenzoic acid Depiction based on curated SMILES + N O N H O _ O O OH O O OH OH Yersinia TTSS secreted effectors Preclinical (in vitro) Leone M, et al. 2010. Chem Biol Drug Des
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  4  5  6  7  8  9  10  11  12  13  14  15 



Back to top
2004-2025 NIPB, CAMS&PUMC